2005
DOI: 10.1016/j.cbpc.2004.10.006
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of bioactive glycolipids from Scytonema julianum (cyanobacteria)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
11
0
1

Year Published

2005
2005
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 27 publications
(14 citation statements)
references
References 18 publications
2
11
0
1
Order By: Relevance
“…For example, glycol analogs of ceramides and of PG with antithrombotic and antiinflammatory activities have been reported in cyanobacteria (Antonopoulou et al 2005).…”
Section: Introductionmentioning
confidence: 99%
“…For example, glycol analogs of ceramides and of PG with antithrombotic and antiinflammatory activities have been reported in cyanobacteria (Antonopoulou et al 2005).…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, their importance has been recently raised by the description of their different biological activity, mainly related to their anti-inflammatory, antitumor-promoting, antialgal, hemolytic and antiviral properties [13]. For example, glycol analogs of ceramides and of PG with anti-thrombotic and antiinflammatory activities have been reported in cyanobacteria [14].…”
Section: Introductionmentioning
confidence: 99%
“…Some studies have shown that even monosugar α-galactosylceramide glycolipid (α-GalCer) could cause a strong immune response, potently induce antitumor immunity through increasing IL-12 production by dendritic cells [55] and can activate iNKT cells and protect mice against a variety of diseases, including cancer, infection and several autoimmune and inflammatory conditions in preclinical studies [10]. Phosphoglycolipids of the cyanobacterium Scytonema julianum antagonize the actions of platelet-activating factor [56].…”
Section: Discussionmentioning
confidence: 99%